| Tag | Content |
|---|
EnhancerAtlas ID | HS133-03625 |
Organism | Homo sapiens |
Tissue/cell | melanoma |
Coordinate | chr1:224019400-224021050 |
Target genes | | Number: 11 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| JUN(var.2) | MA0489.1 | chr1:224019681-224019695 | TAAGAATGACTCAT | + | 6 | | Sox6 | MA0515.1 | chr1:224019596-224019606 | AAAACAATGG | - | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09755 | chr1:224018879-224024980 | CD14 | | SE_18793 | chr1:224018897-224025157 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19882 | chr1:224019081-224022196 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 224019418 | 224020617 | | chr1 | 224019430 | 224020596 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I223831 | chr1 | 224018704 | 224025501 |
|
Enhancer Sequence | TACAACTTGT TTCTACCTCC TATAGTCATC TATCTCAAGA GAAGGAAAGT CGAAGGAAAG 60
ATAAAAAAAA AAAAAAAACA CTGTGTTAAG TTGTGCCAGG CCACCTACAG GCACACTGCA 120
TAGTAATTCA TGTCAGTCAT ATCTAGATGA AGATGTGCCC TTCCAAAAAT TCAAAGTCAC 180
AGATAATTTT CATTTAAAAA CAATGGGTCA TAGATTTATT TTAAGAGTCC TGTGTTTATA 240
GAGCATGTAT GTACTGTAAC TATGATGTTA TGCTATCAAC ATAAGAATGA CTCATTTTAA 300
AGAGGAATTA TTTCAGATCA AAATCTGAAA GACTTTTCTA AGAGGAAATA CAAAAAAAAA 360
ACTGATTAGG GCATTTACAA GATGAGTCAG AGGCTAACAT TTATTCATTT GATTCAGAAA 420
ATCATGTGAA GTTCTACAGA AAGAAGAAAG GAACCAAGAG TATAAGATGT TCCCTGTCAC 480
CAAAGGGAAA TTACGCTCTA CAACAGCACC TTCAGAGTTT TCATTTACAA AAACTCAAAT 540
CCTTCAAGTT TACCTAAGAG GAAGAAACAG AAAATTATGA AATGAACAAT CTATAAAAAG 600
AGTGACACAA ATCCTCCCCA AATTTTGCAA CTCACAAGAA ATACCACAGG AATAGCCAGG 660
CGATTATGCT TGTAGAGAGA TTAGGGGAAA ATCTGAATGG TTTCTGTGTT TCACAATTCC 720
TCTGCAGAAA GATAAATGTA AAACTATTAC TTCAGTTTCT ATATTTTGTT GTACCCCTTA 780
TGGAGGCAGG CCCGAAAATA TTTCTTGTAA GAGGAGAATG CCACTAGGCT TCCTATAACC 840
CAGTCAAGCA AAAACACCTC TCCCAACACT GTGATACAGA GTGGGGATTA AATTAAGATA 900
TAACCAAAGT TTCTTTCAAA CTCATACACA GCCATTTAGC CCAACTATGA CTTCTAACAC 960
TGGGCGGGGT TTAGGAAGGA GATGCCGACC CTTCCAGTCC TCAAGAGTAC TCTGCCTGTC 1020
TCTGCACAGA CCTGGAGCTC TGCTCCAATG CTCACTCTGC CAGCTGAGTC TGCACACCAA 1080
GGGCACTCAT GAGCTTGGCT CCCTAATTCA GACATGCTGC ACCCTAGCTG TGAGCTAGGC 1140
TGCCAGTCTT CTGCAAGAAG TGTGCTGCTC CACTACCCCA GCTTGAGCTT GAGCTGTCCT 1200
TCCTCGTCTC CCCAATATCT GAGTAGGCAA CCCACAGGGG TCTCTGTGGA ACCTTCCTCA 1260
GGAGCCACAG GGACACTACA TATTTGAGTC CTTTCCCTCA AAGAGACACT CTCTACCTCC 1320
CTGACGATGG GTCCCAACCT TATTAAAGTT ATCAGAGAAT CACTGCTTAC AAAGGCCTAT 1380
CATGATTTCT TAGCTGTTTC TCTAGAGTTT ACTCTTGGAG CCATTAAACT GCTTTTAAAA 1440
ATATTCACCA ATTACCATAA GTTATGTATA CCGATGTTCT ATTAAGGCTC AATGATATTA 1500
AACCTACTTC TACACTAAGT GTACCACTTT ATATGATGGC ATATTTTTAA CATTAACCCA 1560
TCAGTTCCTA TCAGTTACAT CTGAGTTTAT TTAAAGCAAA ATCATAAAGT CATATTCAAA 1620
GGATTTTTTT TACTTCATAA ACTATTCCTT 1650
|
